Simultaneous Estimation of Baclofen and Nimesulide: Method Development and Validation by UV-Spectrophotometric Method

Authors

  • Amit B. Patil Department of Pharmaceutical Sciences, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, India
  • Nandini Bangera Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte University, Paneer, Deralakatte, Mangalore, India

Abstract

A simple, accurate, precise, reproducible and economical UV spectroscopic methods for simultaneous estimation of Baclofen and Nimesulide in tablet dosage form have been developed. The method is based on the principle of Q-Analysis where in the absorbance was measured at 227 nm (iso-absorptive point) and 218 nm (λmax of Baclofen) in simulated gastric fluid (pH 1.2). Baclofen and Nimesulide show linearity at all the selected wave- lengths and obeys Beer’s law in the concentration range of 4–32 and 5–75 µg/mL respectively. Recovery studies for Baclofen and Nimesulide were performed and the percentage recovery for both the drugs was obtained in the range of 98.0–100.4% confirming the accuracy of the proposed method. Both the methods showed good reproducibility and recovery with %RSD less than 2. Statistical validation of the data shows that the proposed method can be successfully applied for the routine analysis of drugs in commercial tablets.

 

Keywords: Baclofen, Nimesulide, UV spectroscopic methods, simultaneous estimation

Cite this Article

Amit B. Patil, Nandini Bangera, Simultaneous Estimation of Baclofen and Nimesulide: Method Development and Validation by UV-Spectrophotometric Method, Research & Reviews: A Journal of Drug Design & Discovery. 2015; 2(2): 6–11p.

Downloads

Published

2019-03-01

Issue

Vol. 2 No. 2 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.